Answers are grounded in this paper and cite their sources.
An analysis of the use ofin vitrotechniques in preclinical safety testing revealed a marked increase to >180 000 tests/year by 2012. Step changes in uptake were notable in the three main areas of ADME, safety pharmacology and genetic toxicology, correlated with relevant ICH guidelines.
No takes yet. Share an insight, caveat, or question.
Goh et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: